Introduction
============

Huanglongbing (HLB) or citrus greening disease has caused devastation to the citrus industry around the world, with no solutions in sight ([@B7]; [@B5]; [@B11]; [@B17]). Three species of phloem-limited α-proteobacteria have been associated to HLB in different parts of the world: *Liberibacter asiaticus, L. americanus*, and *L. africanus* ([@B26]; [@B48]). In the USA, *L. asiaticus* has been identified as the causal agent of HLB ([@B26]). While several efforts had been made to culture this microorganism in laboratory conditions, they have had little success in sustaining growth as axenic cultures ([@B46]; [@B40]). Analyses of the genome sequence revealed that *L. asiaticus* possesses a very simple gene regulatory system, where only 10 transcription factors may control the expression of the entire transcriptome. Based on these observations, we hypothesized that these transcription factors could be used as targets for the development of new therapeutics. LdtR is a member of the MarR family of transcriptional regulators. It acts as a transcriptional activator by binding to the promoter region of the *ldtR* and the downstream gene *ldtP*. Based on sequence identity, *ldtP* was predicted as a [L,D]{.smallcaps}-transpeptidase. We found that in the closely related species *Sinorhizobium* *meliloti*, the inactivation of *ldtR* or *ldtP* resulted in morphological changes and reduced tolerance to osmotic stress ([@B37]). These results indicated that LdtP might play a role in the remodeling of the cell wall in *L. asiaticus*, although it has not been biochemically characterized yet. Based on the reduced survival of the *ldtR* mutant under osmotic stress conditions and the biological relevance of fluctuations in osmolarity in the phloem sap for *L. asiaticus*, LdtR was used as a target for the design of antimicrobials. Using a small molecule screening assay, we identified phloretin, hexestrol, and benzbromarone as inhibitors of LdtR binding to DNA. These observed *in vitro* effects were correlated with a decreased transcriptional activity of *L. asiaticus* in infected citrus shoots after incubation with these chemicals ([@B37]). Due to the strong effect observed for benzbromarone, it was chosen for further mechanistic studies. Benzbromarone is a non-purine drug that act as a non-competitive analog of the xanthine oxidase. It has been used for more than 30 years in several countries as a therapeutic agent for the treatment of gout, since it reduces the absorption of uric acid in the kidneys ([@B24]). In humans, benzbromarone is metabolized in the liver by the cytochrome P450 mono-oxygenase and excreted through the bile ([@B14]; [@B9]).

Members of the MarR family of transcriptional regulators are small proteins that work as sensors of environmental changes ([@B51]), and have been extensively associated with multidrug resistance. However, after years of research it is clear that MarR homologs regulate a variety of metabolic pathways and they are not restricted to the initial assigned role ([@B35]; [@B43]; [@B47]; [@B50]; [@B25]; [@B22]; [@B8]).

The majority of the reported MarR homologs, negatively regulate transcription by binding as dimers to a DNA sequence located in the promoter region ([@B41]; [@B19]). Upon binding of a signal molecule in the dimer interface, these transcription factors lose DNA binding capabilities, allowing transcription to occur. In contrast, only few reports have described MarR family members acting as transcriptional activators ([@B4]; [@B32]; [@B10]; [@B31]; [@B38]). These include ChlR, a transcription activator that utilizes an oxygen-labile \[4Fe--4S\] cluster to sense oxygen in *Synechococcus* sp. PCC 7002 ([@B31]); BdlR, a transcriptional activator involved in the detoxification of aromatic compounds in the archaea *Sulfolobus solfataricus* ([@B10]); and SarR, a transcriptional activator involved in the up-regulation of virulence genes in *Staphylococcus aureus* ([@B32]). While the roles of these regulators have been addressed, very little is known about the ligand binding pockets or the signal molecules that modulate their activity.

In contrast, several MarR repressors have been described at the molecular level, in presence and absence of inducer molecules ([@B13]; [@B51]; [@B45]; [@B29]; [@B42]; [@B38]). The structure of MTH313 from *Methanothermobacter thermautotrophicus* was elucidated in presence of salicylate in the dimerization interface, in two asymmetrical pockets. The first site, named SAL1, is located between the dimer interface and the DNA binding domain, while SAL2 was found asymmetrically located 5 Å away from the corresponding symmetrical site ([@B45]). In the crystal structure of ST1710 from *Sulfolobus tokodaii*, salicylate was found only in the corresponding SAL1 pocket ([@B29]). Based on the location of the SAL2 pocket in MTH313, and the findings of a unique salicylate molecule in ST1710, the biological relevance of the SAL2 site remains unknown in those proteins.

Here, we directed our research to the identification of the binding site of benzbromarone in LdtR, as a step in the understanding of the mechanism of ligand sensing by a MarR protein that acts as a transcriptional activator. Since currently there are not any available structures for MarR members that have been biochemically or genetically characterized as transcriptional activators, we used an unbiased *in silico* modeling to determine the binding site of benzbromarone. Using site-directed mutagenesis we characterized the ligand binding pocket of LdtR. The decreased ligand binding affinities observed for some LdtR mutants *in vitro* was confirmed using *in vivo* experiments in model strains. The results obtained contribute to the understanding of the protein--ligand interaction in the MarR family of transcriptional activators, and provides foundations for the designs of new therapeutics against HLB.

Materials and Methods {#s1}
=====================

Bacterial Strains
-----------------

*Escherichia coli* DH5α cells were used to carry and propagate all vectors. Cultures were grown in Luria-Bertani medium (LB, Difco) at 37°C. *Bacillus subtilis* strains were grown in LB medium at 37°C. *S. meliloti* strains were grown at 30°C in either LB medium or M9 minimal medium with glucose. All strains were grown under aerobic conditions.

When necessary, media was supplemented with ampicillin (100 μg/ml) for *E. coli*; neomycin (100 μg/ml), gentamicin (30 μg/ml), and streptomycin (500 μg/ml) for *S. meliloti*; or with erythromycin (1 μg/ml) for *B. subtilis*. All antibiotics and chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). The strains used for this study are listed in **Table [1](#T1){ref-type="table"}**.

###### 

Strains and plasmid used in this study.

  Name                            Relevant genotype                                                                                                                          Origin/reference
  ------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------
  **Bacterial strains**                                                                                                                                                      
  *Escherichia coli* DH5α         φ80 d*lacZ*ΔM15Δ(*lacZYA-argF*)U169 *recA1 endA1 hsdR17* (rk^-^. mk^+^) *supE44 thi-1 gyrA relA1*                                          Laboratory stock
  *E. coli* BL21 (DE3)            *F -- ompT gal dcm lon hsdSB*(*rB- mB-*) *aaa*(*DE3* \[*lacI lacUV5-T7 gene 1 ind1 sam7 nin5\]*)                                           Life Technologies
  *Bacillus subtilis* 168         *trpC2*                                                                                                                                    *Bacillus* Genetic Stock Center
  *Sinorhizobium meliloti* 1021   *expR102*::IS*Rm*2011-1 *expR*. Sm^r^                                                                                                      [@B16]
  BS6                             168 *ΔthrC*::\[*P~ldtR~-ldtR-P~ldtP~* (-395 to +792)*-lacZ*\]. Em^r^                                                                       [@B37]
  BS6A                            BS6 *ldtR*(T43A). Em^r^                                                                                                                    This work
  BS6B                            BS6 *ldtR*(L61A). Em^r^                                                                                                                    This work
  BS6C                            BS6 *ldtR*(F64A). Em^r^                                                                                                                    This work
  SMP2                            *S. meliloti* 1021 *ldtR~SMc~* (+29)::*uidA*. Sm^r^. Neo^r^                                                                                [@B37]
  SMP2A                           *S. meliloti* SMP2 pBBR1MCS-5. Sm^r^. Neo^r^. Gm^r^                                                                                        [@B37]
  SMP2B                           *S. meliloti* SMP2 pSMP4. Sm^r^. Neo^r^. Gm^r^                                                                                             [@B37]
  SMP4A                           *S. meliloti* SMP2 pSMP4 (T43A). Sm^r^. Neo^r^. Gm^r^                                                                                      This work
  SMP4B                           *S. meliloti* SMP2 pSMP4 (L61A). Sm^r^. Neo^r^. Gm^r^                                                                                      This work
  SMP4C                           *S. meliloti* SMP2 pSMP4 (F64A). Sm^r^. Neo^r^. Gm^r^                                                                                      This work
  SMP5                            1021 \[*pBBR1MCS-5*\]. Sm^r^. Gm^r^                                                                                                        This work
  **Plasmids**                                                                                                                                                               
  p15TV-L                         Expression vector for purification of proteins by nickel affinity chromatography. Ap^r^                                                    [@B39]
  pDG1663                         *B. subtilis* vector for ectopic integration into *thrC* site containing *E. coli spoVG-lacZ*. Ap^r^, Em^r^                                [@B20]
  pRK600                          Helper plasmid for triparental mating. pRK2013 Nm::Tn9. Cm^r^                                                                              [@B36]
  pBS6                            *P~ldtR~-ldtR-P~ldtP~-lacZ* transcriptional fusion carrying *Liberibacter asiaticus s*equence from -395 to +792 in pDG1663. Ap^r^, Em^r^   [@B37]
  pBS6A                           pBS6 (T43A). Ap^r^, Em^r^                                                                                                                  This work
  pBS6B                           pBS6 (L61A). Ap^r^, Em^r^                                                                                                                  This work
  pBS6C                           pBS6 (F64A). Ap^r^, Em^r^                                                                                                                  This work
  pSMP2                           407 bp of *PldtR~SMc~ and ldtR~SMc~* (from -378 to +29) in pVMG. Neo^r^                                                                    [@B37]
  pBBR1MCS-5                      Broad host range vector. Gm^r^                                                                                                             [@B28]
  pSMP4                           *ldtR* (from +1 to +516) cloned into pBBR1MCS-5 (EcoRI/BamHI). Gm^r^                                                                       [@B37]
  pSMP4A                          pSMP4 (T43A). Gm^r^                                                                                                                        This work
  pSMP4B                          pSMP4 (L61A). Gm^r^                                                                                                                        This work
  pSMP4C                          pSMP4 (F64A). Gm^r^                                                                                                                        This work

DNA Manipulations and Gene Cloning
----------------------------------

Standard methods were used for chromosomal DNA isolation, restriction enzyme digestion, ligation, transformation, and agarose gel electrophoresis ([@B44]). Plasmids were isolated using QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA, USA) and PCR products were purified using QIAquick purification Kit (Qiagen).

Site-directed mutagenesis was performed using the QuikChange Site-directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's protocol. The plasmids p15TV-LdtR, pBS6 ([@B37]), and pBBR1MCS5-LdtR were used as the templates. All selected amino acids were changed to alanine. Mutations were verified by DNA sequencing using T7 and M13 primers. The new generated strains and primers used are described in detail in **Tables [1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**, respectively.

###### 

Oligonucleotides used in this work.

  Primer                          Oligonucleotide sequence (5′→3′)
  ------------------------------- ----------------------------------------------------
  **Site-directed mutagenesis**   
  LdtR_V26A_Fw                    gatatctctggtctatatgcggaatgcttgcgtttggtt
  LdtR_V26A_Rv                    aaccaaacgcaagcattccgcatatagaccagagatatc
  LdtR_R30A_Fw                    ctatatgtggaatgcttggctttggttgagcgattacac
  LdtR_R30A_Rv                    gtgtaatcgctcaaccaaagccaagcattccacatatag
  LdtR_E33A_Fw                    ggaatgcttgcgtttggttgcgcgattacacagaagtcttttgg
  LdtR_E33A_Rv                    ccaaaagacttctgtgtaatcgcgcaaccaaacgcaagcattcc
  LdtR_R34A_Fw                    ggaatgcttgcgtttggttgaggcattacacagaagtcttttgg
  LdtR_R34A_Rv                    ccaaaagacttctgtgtaatgcctcaaccaaacgcaagcattcc
  LdtR_R37A_Fw                    cgtttggttgagcgattacacgcaagtcttttggatgttacaagg
  LdtR_R37A_Rv                    ccttgtaacatccaaaagacttgcgtgtaatcgctcaaccaaacg
  LdtR_T43A_Fw                    agaagtcttttggatgttgcaagggatgagtttgaaaga
  LdtR_T43A_Rv                    tctttcaaactcatcccttgcaacatccaaaagacttct
  LdtR_L61A_Fw                    gtgaatgctgtgcaagcagctttacttttcaatataggtg
  LdtR_L61A_Rv                    cacctatattgaaaagtaaagctgcttgcacagcattcac
  LdtR_F64A_Fw                    gctgtgcaagcacttttacttgccaatataggtgatcttgagttaacagc
  LdtR_F64A_Rv                    gctgttaactcaagatcacctatattggcaagtaaaagtgcttgcacagc
  LdtR_N65A_Fw                    gctgtgcaagcacttttacttttcgctataggtgatcttgagttaacagc
  LdtR_N65A_Rv                    gctgttaactcaagatcacctatagcgaaaagtaaaagtgcttgcacagc
  LdtR_Y81A_Fw                    ggagaattacgttcaagaggagcttatttgggttctaatgtatc
  LdtR_Y81A_Rv                    gatacattagaacccaaataagctcctcttgaacgtaattctcc
  LdtR_Y82A_Fw                    ggagaattacgttcaagaggatatgctttgggttctaatgtatc
  LdtR_Y82A_Rv                    gatacattagaacccaaagcatatcctcttgaacgtaattctcc
  LdtR_Y131A_Fw                   gagactatttctcaactcgctcaacgtcatatagagtcg
  LdtR_Y131A_Rv                   cgactctatatgacgttgagcgagttgagaaatagtctc
  **Sequencing**                  
  M13_Fw                          gttgtaaaacgacggccagt
  M13_Rv                          aggaaacagctatgaccatg
  T7                              taatacgactcactataggg
  T7 term                         gctagttattgctcagcgg

Protein Purification
--------------------

Protein expression and purification was performed as described previously ([@B37]). Briefly, the His-tagged fusion proteins were overexpressed in *E. coli* BL21-Star(DE3) cells (Life Technologies, Grand Island, NY, USA). The cells were grown with shaking in LB broth at 37°C. Protein expression was induced with 0.5 mM IPTG at OD600 = 0.5. After addition of IPTG, the cells were incubated with shaking at 17°C overnight. The cells were recovered by centrifugation and the pellet resuspended in binding buffer (500 mM NaCl, 5% glycerol, 50 mM Tris pH 8.0, 5 mM imidazole, and 0.5 mM TCEP), and stored at -80°C. The thawed cells were lysed using a French Press, and the lysate centrifuged at 15,000 rpm for 30 min at 4°C. The cell free extract was applied to a metal chelate affinity-column charged with Ni^2+^ (Qiagen). After the column was washed with binding buffer supplemented with 25 mM imidazole, the protein was eluted using elution buffer (binding buffer with 250 mM imidazole). The six-histidine tag was removed from the eluted proteins by treatment with a recombinant His-tagged TEV protease. The cleaved protein was separated from the hexa-histidine tag and the TEV protease by passing the samples through a second column charged with Ni^2+^. Finally, the eluted cleaved proteins were dialyzed against 500 mM NaCl, 5% glycerol, 50 mM Tris pH 8.0, and 0.5 mM TCEP. After dialysis the proteins were aliquoted and stored at -80°C. Protein concentration was determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA).

Electrophoresis Mobility Shift Assays (EMSAs)
---------------------------------------------

Gel shift assays of LdtR wild type (WT) and LdtR mutants over DNA containing *P~ldtP~* were conducted using proteins purified and stored according to the procedures described above. Fragments of the *ldtP* promoter were generated by PCR as described previously ([@B37]). The reaction mix for electrophoresis mobility shift assay (EMSA) contained 1 ng of 5′-Biotin labeled DNA probe, 50 mM Tris-HCl pH 7.2, 150 mM KCl, 10 mg MgCl~2~, 0.01% Triton X100, 12.5 ng/μl Poly(dI-dC) and Poly(dA-dT) non-specific competitor DNAs, purified WT or mutant LdtR (0--800 nM), and benzbromarone (0--1 mM), when indicated. After incubating the mix for 20 min at 37°C, the samples were electrophoresed at 4°C on a 6% acrylamide/bisacrylamide non-denaturing gels, in 0.5X Tris-borate EDTA buffer (TBE) pH 8.3. Then, the DNA was transferred from the polyacrylamide gel to a Hybond-N^+^ membrane (GE Healthcare, Pittsburgh, PA, USA) by electroblotting at 250 mA for 45 min in a semidry transfer (Fisher Scientific, Pittsburgh, PA, USA). The transferred DNA was UV-crosslinked and the biotin labeled DNA was detected using the Phototope-Star Detection Kit (New England Biolabs, Ipswich, MA, USA). Membranes were exposed to Kodak X-ray films. Benzbromarone was prepared as a 100 mM stock solution in 100% DMSO. It was further diluted in LdtR's dialysis buffer for EMSAs. Vehicle controls were included in all the assays.

Size-exclusion Chromatography
-----------------------------

Protein samples of 100 μL contained 10 μM WT or LdtR mutants, 50 mM Tris pH 8.0, 500 mM NaCl, and 5% glycerol. The sample was incubated 20 min on ice and then injected onto a prepacked Superose 12 10/300 GL gel filtration column (GE Healthcare), connected to a LCC-501 plus (GE Healthcare), and equilibrated with 50 mM Tris pH 8.0, 500 mM NaCl, and 5% glycerol. Filtration was performed in a flow rate of 0.5 ml/min at 4°C. The eluted protein was checked continuously for absorbance at 280 nm using a UV-M II monitor (GE Healthcare). The void volume of the column was determined using Blue dextran 2000. A combination of protein molecular weight standards, including IgG (150 kDa), BSA (66 kDa), Albumin (45 kDa), Trypsinogen (24 kDa), Cytochrome C (12.4 kDa), and Vitamin B12 (1.36 kDa) was applied to the column under the same conditions. The elution volume and molecular mass of each protein standard was used to elaborate a standard curve for further determination of the molecular weight of LdtR and LdtR mutants in the ligand binding pocket. The theoretical molecular weight of LdtR and the mutants was calculated from the amino acid sequence using the Compute pI/Mw tool at the ExPASy Proteomics Server (<http://ca.expasy.org/tools/pi_tool.html>).

Thermal Stability Screening by Differential Scanning Fluorimetry
----------------------------------------------------------------

Wild type LdtR and mutants in the ligand binding pocket were screened against different concentrations of benzbromarone (0--65 μM), as previously described ([@B49]; [@B37]). Proteins were diluted to a final concentration of 30 μM, using 100 mM Tris pH 8.0 and NaCl 150 mM. SYPRO orange (Life Technologies) was added to a final concentration of 5X. Aliquots of 25 μL of protein solution were placed in triplicates in 96-well plates (Bio-Rad), and heated from 25 to 80°C at the rate of 1°C per min. A multicolor real-time PCR detection system (iCycler iQ, Bio-Rad) was used to monitor the unfolding of LdtR, by measuring the increase in the fluorescence of the SYPRO orange. Fluorescence intensities were plotted against temperature for each sample and the generated curves were fitted using the Bolztmann equation with Origin 9 software (Northampton, MA, USA). The midpoint of each transition was calculated and compared to the calculated midpoint for the reference/control sample.

Isothermal Titration Calorimetry
--------------------------------

Measurements were conducted in a MicroCal ITC200 system (GE Healthcare) at 30°C. WT LdtR mutants in the ligand binding pocket were dialyzed overnight against 500 mM NaCl, 5% glycerol, 50 mM Tris pH 8.0, and 0.5 mM TCEP. A solution of 0.5 mM benzbromarone was directly prepared in dialysis buffer. Each titration consisted in a series of 1 μl injections of the ligand into the protein solution. The mean enthalpies measured from injection of the ligand into the buffer were subtracted from raw titration data prior to analysis. Titration curves were fitted by a non-linear least squares method, using Origin 9 software, to a function for the binding of a ligand to a macromolecule ([@B52]). From the curve thus fitted, the parameters Δ*H* (reaction enthalpy), *K~A~* (binding constant, *K~A~* = 1/*K~D~*), and *N* (reaction stoichiometry) were determined. From the values of *K~A~* and Δ*H*, the changes in free energy (Δ*G*) and entropy (Δ*S*) were calculated with the equation Δ*G =* -RT ln*K~A~* = Δ*H* - TΔ*S*, where R is the universal molar gas constant and T is the absolute temperature.

Construction of Complemented Strains of *S. meliloti*
-----------------------------------------------------

Plasmid pBBR1MCS5 or its variants pSMP4, pSMP4A-C, harboring the copy of WT LdtR or with mutations in the ligand binding pocket (**Table [1](#T1){ref-type="table"}**), were propagated in DH5α, and mobilized into *S. meliloti* SMP2 strain by triparental mating with the aid of plasmid pRK600 ([@B15]). Transconjugants were selected on M9 medium supplemented with 0.4% sucrose, 120 μg/ml neomycin, 500 μg/ml streptomycin, and 90 μg/ml gentamicin plates. The presence of the plasmids were confirmed by PCR using universal M13 primers.

*S. meliloti* Osmotic Stress Assays
-----------------------------------

For the osmotic stress assays, *S. meliloti* cells were grown in M9-glucose minimal broth, supplemented with increasing concentrations of NaCl (8.5--200 mM) in the presence or absence of 25 μM benzbromarone. The OD600 of cells grown in M9 minimal media was continuously monitored, and the growth rate constant (*k*) was calculated as the slope of a plot containing the log~2~OD600 versus time, during the exponential phase of growth. The mean generation time (*g*) was calculated as 1/*k*. The assays were performed in triplicates.

Construction of *lacZ* Fusions in *B. subtilis*
-----------------------------------------------

The strains used for the β-galactosidase assays were constructed as described in [@B37] and are listed in **Table [1](#T1){ref-type="table"}**.

β-Galactosidase Assays
----------------------

The β-galactosidase assays were conducted in *B. subtilis* cells grown at 37°C in LB medium, in absence or presence of different concentrations of benzbromarone (0.1--2.5 μM). After the cultures reached an OD600 = 0.3 (mid-exponential phase), the cells were collected and washed twice with 0.9% NaCl, and then permeabilized with 1% toluene in Z-buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, 10 mM KCl, 1 mM MgSO~4~, 50 mM β-mercaptoethanol; [@B34]). β-galactosidase activity was assayed by following the hydrolysis of chlorophenol red-β-[D]{.smallcaps}-galactopyranoside (Sigma-Aldrich). The absorbance at 570 nm was read continuously using a Synergy HT 96-well plate reader (BioTek, Winooski, VT, USA). β-galactosidase activity, expressed as arbitrary units (AUs), was calculated using the slope of absorbance curve normalized with the initial cell density (OD600). The assays were performed in triplicates.

Statistical Analyses
--------------------

The statistical significance of the β-galactosidase activities was determined using a Student's *t*-test.

Results
=======

Model of Benzbromarone Binding in LdtR
--------------------------------------

LdtR was modeled *in silico* using the automated mode of the SWISS-MODEL server ([@B3]), and PHYRE2 server ([@B27]). The crystal structure of SP03579 from *Ruegeria pomeroyi* DSS-3 (PDB\# 3BJ6) was retrieved as the best template, despite sharing low sequence identity (21%). Since LdtR, as well as other members of the MarR family are commonly found as homodimers in solution ([@B41]), a model of the dimer was generated using 3BJ6 as a template (see Supplementary Data Sheet 2).

The molecular interactions between the LdtR dimer and benzbromarone were predicted using the SwissDock web server ([@B18]), and the DockingServer web interface ([@B23]). The molecule of benzbromarone was docked in a variety of orientations within one pocket symmetrically located on both dimer interfaces (**Figure [1A](#F1){ref-type="fig"}**). One molecule of benzbromarone docked with a predicted Gibbs free energy (Δ*G*) of -8.97 kcal/mol, and it was located between helices Aα1-Aα2-Aα5, and Bα1 (A, chain A; B, chain B, **Figure [1A](#F1){ref-type="fig"}**). The other molecule docked with a predicted Δ*G* of -7.49 kcal/mol between helices Bα1-Bα2-Bα5, and Aα1 (**Figure [1A](#F1){ref-type="fig"}**).

![**LdtR model and identification of critical amino acids involved in ligand interaction.** Structural-based identification of residues involved in ligand binding in LdtR. The protein is shown in cartoon representation, with each subunit in a different color (monomer A, orange; monomer B, green), whereas ligands and selected amino acid side chains are shown in sticks representation and labeled, coloring O, N, and Br atoms in red, blue and magenta, whereas the C atoms are shown in yellow for the ligands and in the color of the corresponding subunit for amino acid side-chains. **(A)** Model of the LdtR dimer, with benzbromarone docked in both subunits, suggesting the presence of one ligand binding pocket per subunit. **(B)** Close view of the predicted Benz1 pocket oriented to show the amino acid residues that would be within 4 Å from the docked ligand. **(C)** Ribbon representation of the modeled LdtR dimer superimposing on it the salicylate molecules found in the SAL1 and SAL2 sites of the homologous protein MTH313 of *Methanothermobacter thermautotrophicus* (PBD\# 3BPX, [@B45]). **(D)** Close view of the Benz2 pocket, formed by the amino acid residues within a distance of 4 Å of the LdtR SAL2-equivalent pocket.](fmicb-06-01314-g001){#F1}

In both cases, benzbromarone interacts with residues V26, R30, R37, T43, L61, F64, N65, Y81, and Y131 (**Figure [1B](#F1){ref-type="fig"}**). In the most favorable model, L61 interacts with benzbromarone carbon atoms C9 and C10 via hydrophobic interactions. Similarly, F64 was predicted to establish hydrophobic interactions with atoms C13-C14-C15-C16 of benzbromarone. T43 was found to establish polar interactions with atom O3. Residue N65 was predicted to establish a halogen bond with Br1, although this interaction was predicted to be less favorable. The type of interaction between other residues of the pocket with benzbromarone could not be predicted.

The docked model of LdtR with benzbromarone was then compared to the structure of MTH313 with salicylate (PDB\# 3BPX; [@B45]). We found that the SAL1 pocket in MTH313 aligned with the location where benzbromarone docked with a Δ*G* of -7.49 kcal/mol. This SAL1 equivalent pocket in LdtR was named Benz1 (**Figures [1B,C](#F1){ref-type="fig"}**). SAL2 did not align with any of the predicted pockets in LdtR, due to the asymmetric location of salicylate in the crystal structure of MTH313. The structural alignment between LdtR and MTH313 also served to identify the equivalent residues for SAL2 in LdtR. The residues E33, R34, and Y82 in LdtR were identified within a distance of 4 Å of the salicylate molecule (**Figure [1D](#F1){ref-type="fig"}**). This pocket in LdtR was named Benz2.

To determine which of the amino acids in the predicted Benz1 and Benz2 pockets in LdtR are biochemically and biologically relevant, site-directed mutagenesis (to alanine) was conducted on all of them. The mutant proteins were purified and analyzed by size exclusion chromatography, and confirmed that the mutations did not affect dimer formation in solution (data not shown).

Mutations in LdtR Reduce Binding to *P~ldtP~*
---------------------------------------------

The binding pockets Benz1 and Benz2 are located in the dimerization domains of LdtR. Previous studies of MarR homologs have reported that that mutagenesis in the dimerization interface can directly affect DNA binding activity ([@B45]; [@B39], [@B38]; [@B21]). Based on these observations, the purified LdtR mutant variants were tested for DNA binding activity on the promoter region of the downstream gene *ldtP* (*P~ldtP~*; [@B37]). Under the current DNA binding assays conditions, an approximated 50% of binding of LdtR WT to *P~ldtP~* was achieved at 200 nM (**Figure [2](#F2){ref-type="fig"}**). Under these conditions, only one LdtR:DNA complex was observed. In Benz1 pocket of LdtR, mutants V26A, R37A, and Y81A had similar binding affinities for *P~ldtP~* when compared to the WT LdtR. Mutants R30A, T43A, L61A, F64A, N65A, and Y131A showed decreased affinity for DNA, reaching around 50% of binding to the DNA at approximately 400 nM of protein (**Figure [2](#F2){ref-type="fig"}**). Conversely, LdtR mutants E33A, R34A, and Y82A, located in the Benz2 pocket, displayed binding affinities for *P~ldtP~* similar to the WT LdtR (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). The decreased binding to DNA observed in some mutants suggest that these residues play a role in the stabilization or flexibility of the dimer form of LdtR (**Figure [1B](#F1){ref-type="fig"}**).

![**LdtR mutants in residues R30, T43, L61, F64, N65, and Y131 bind DNA with lower affinity compared to the WT LdtR.** *P~ldtP~* DNA probe was incubated with increasing concentration of WT LdtR or mutants in the Benz1 pocket (V26A, R30A, R37A, T43A, L61A, F64A, N65A, Y81, and Y131A), as indicated on top of each panel. No protein was added to the first lane.](fmicb-06-01314-g002){#F2}

The ability of these LdtR mutant proteins to sense and respond to benzbromarone was then tested at the conditions where around 50% of binding to DNA was achieved. In Benz1, the mutant protein in residues R30, R37, F64, Y81, and Y131 interacted with benzbromarone similarly to the WT LdtR, with disruption of the complex occurring at a 10-fold excess of benzbromarone (**Figure [3](#F3){ref-type="fig"}**). However, LdtR mutants V26A, T43A, and N65A required a 20-fold excess of benzbromarone to disrupt the complex (**Figure [3](#F3){ref-type="fig"}**). Interestingly, the L61A mutant no longer responded to benzbromarone (**Figure [3](#F3){ref-type="fig"}**). These results suggest that V26, T43, L61, and N65 might be involved in the interaction of LdtR with benzbromarone *in vitro*.

![**LdtR residues V26, T43, L61, and N65 may mediate binding to benzbromarone.** *P~ldtP~* DNA probe and WT LdtR or mutants in the Benz1 pocket (V26A, R30A, R37A, T43A, L61A, F64A, N65A, Y81, and Y131A) were incubated with increasing concentrations of benzbromarone. Since some mutant proteins bind DNA with different affinities (**Figure [2](#F2){ref-type="fig"}**), the benzbromarone:LdtR molar ratio was kept constant, as indicated on top of each panel. No protein was added to the first lane.](fmicb-06-01314-g003){#F3}

The LdtR mutants in Benz2, E33A, R34A, and Y82A, bound benzbromarone similarly to the WT LdtR, disrupting the complex formation at similar ratios (data not shown). These results indicate that the residues in the Benz2 pocket may not be relevant for the protein--ligand interactions in LdtR. These results also suggest that benzbromarone binds LdtR in one pocket located in the dimerization interface (Benz1).

Mutations in Benz1 Affect the Thermal Stability of LdtR
-------------------------------------------------------

A fluorescence based screening assay was used to assess the thermal stability of mutants in the Benz1 pocket ([@B39]; [@B33]). In the absence of benzbromarone the *Tm* of the WT LdtR was 45.1 ± 0.2°C. The mutant Y81A showed a similar *Tm* (44.9 ± 0.12°C) compared to the WT LdtR. The substitution to alanine in residues R37, N65, and Y131 increased their thermal stability (47.8 ± 0.03°C, 46.9 ± 0.14°C, and 46.7 ± 0.25°C, respectively; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), while changes in residues V26, R30, T43, and L61 decreased their thermal stability (40.1 ± 0.01°C, 41.3 ± 0.05°C, 42.3 ± 0.07°C, and 42.4 ± 0.13°C, respectively, Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). These results suggest that these residues may be involved in the stability of the dimer; however, all the mutant proteins behaved as dimers in solution. Additionally, there was no correlation between the potential disturbance in the thermal stability of the dimer and the DNA binding capabilities of the mutants observed in the EMSAs (**Figure [2](#F2){ref-type="fig"}**).

The melting temperature (Δ*Tm*) was measured for each LdtR mutant at increasing ratios of benzbromarone and protein (ranging from 0:1 to 1.5:1). It was found that benzbromarone decreased the stability of WT LdtR in a concentration dependent manner (**Figure [4](#F4){ref-type="fig"}**). At low benzbromarone:LdtR molar ratios (i.e., 0.4:1), the melting temperature of LdtR decreased around 2°C (Δ*Tm* = -1.8 ± 0.2°C), while at a higher ligand:protein molar ratio (i.e., 1.5:1), the melting temperature decreased 3.6 ± 0.2°C.

![**T43A and L61A mutations increase the thermal stability of LdtR in presence of benzbromarone.** The changes in melting temperatures (Δ*Tm*) of WT LdtR (black bars) and each mutant in the Benz1 pocket were calculated at increasing benzbromarone:protein ratios. The changes in melting temperatures (Δ*Tm*) of LdtR mutants are depicted in different colors (V26A: dark gray; R30A: light gray; R37A: white; Y131A: blue; N65A: purple; Y81A: green; F64A: orange; T43A: yellow; and L61A: red).](fmicb-06-01314-g004){#F4}

A similar decrease in thermal stability was observed with mutants V26A, R30A, and R37A when compared to the WT LdtR in presence of different concentrations of benzbromarone (**Figure [4](#F4){ref-type="fig"}**). These results confirm previous observations that residues R30 and R37 may not be involved in sensing benzbromarone. Noteworthy, mutations in residues V26 and Y131 caused a higher decrease in the melting temperature of LdtR (Δ*Tm* = -5.3 ± 0.4°C and -5.9 ± 0.3°C, respectively) at a 1.5:1 ratio. These results suggest that the change to alanine at the residues V26 or Y131, leads to a protein that is easily destabilized in the presence of high concentrations of benzbromarone.

Mutations T43A, L61A, and F64A resulted in proteins more stable to increasing temperatures, and were not destabilized by benzbromarone at 0:1 to 1:1 ratios. At higher benzbromarone:protein molar ratios (1.5:1), F64A displayed a small decrease in the melting temperature (Δ*Tm* = -2.5 ± 0.4°C), while T43A and L61A were not affected. An intermediate effect of benzbromarone was observed in mutants N65A or Y81A at high ligand:protein molar ratios (Δ*Tm* = -3.3 ± 0.4°C, Δ*Tm* = -3.1 ± 0.4°C; for N65A and Y81A, respectively, **Figure [4](#F4){ref-type="fig"}**). Taken together, these results indicate that LdtR might bind benzbromarone through interactions with T43, L61, and F64 residues. Residues N65 and Y81 may be involved in further stabilization of these interactions, as suggested by the initial docking model.

Mutations in Benz1 Decreases the Affinity of LdtR for Benzbromarone
-------------------------------------------------------------------

Isothermal titration calorimetry was used to determine the thermodynamic binding parameters for the interactions between LdtR (WT, T43A, L61A, and F64A) and benzbromarone (**Table [3](#T3){ref-type="table"}**). The mutant V26A was also included due to the conflicting results between EMSA and thermal stability assays.

###### 

Thermodynamic parameters for the calorimetric titration of LdtR with benzbromarone.

  Protein     *N*           *K~D~* \[μM\]   *K~D~* wt/*K~D~*   Δ*H* \[kcal/mol\]   Δ*S* \[cal/mol/deg\]   Δ*G* \[kcal/mol\]
  ----------- ------------- --------------- ------------------ ------------------- ---------------------- -------------------
  Wild type   0.34 ± 0.08   4.0 ± 1.6       1.00               -3.0 ± 1.0          14.9                   -7.5
  V26A        0.30 ± 0.09   9.3 ± 4.6       0.43               -4.7 ± 1.9          7.47                   -7.0
  T43A        0.30 ± 0.10   17.5 ± 7.5      0.23               -5.5 ± 0.8          3.56                   -6.6
  L61A        No binding    No binding      ND                 ND                  ND                     ND
  F64A        0.34 ± 0.15   16.5 ± 6.0      0.24               -7.0 ± 3.9          -1.35                  -6.6

An exothermal heat exchange was observed in the titration of LdtR with benzbromarone, and the data was fitted using a model of "one set of sites" (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}). The dissociation constant (*K~D~*) of WT LdtR for benzbromarone was in the low micromolar range (4.0 ± 1.6 μM), in agreement with the EMSA results (**Figure [2](#F2){ref-type="fig"}**). The stoichiometry of the reaction was around 0.5 moles of benzbromarone per mole of LdtR monomer, which suggest the chemical only binds to one pocket in the LdtR dimer. The affinities of Benz1 mutants for benzbromarone decreased twofold for V26A, and fourfold for T43A and F64A mutants, while the enthalpic contribution to the binding of benzbromarone to L61A mutant was marginal and no detectable affinities could be determined. The stoichiometry of the reaction for T43A and F64A mutants was close to 0.5 moles of benzbromarone per mole of protein. Altogether, these results confirmed the crucial role of residues L61, T43, and F64 from Benz1 in the interaction with benzbromarone.

Residues in Benz1 Modulate the Regulatory Activity of LdtR
----------------------------------------------------------

The ability of LdtR mutants in Benz1 to sense and respond to benzbromarone was tested *in vivo* using a transcriptional fusion to the *lacZ* reporter gene in *B. subtilis* ([@B37]). Mutations R37A, T43A, L61A, F64A, N65A, or Y81A were introduced in *ldtR* contained in plasmid pBS6 (**Table [1](#T1){ref-type="table"}**).

First, the ability of LdtR containing mutations in Benz1 to induce the expression of the *lacZ* reporter gene was determined. It was found that LdtR mutants in R37A, T43A, and N65A had similar values of β-galactosidase activities compared to the WT LdtR (*p* \< 0.05; **Figure [5](#F5){ref-type="fig"}**). However, mutants L61A, F64A, and Y81A showed a 20, 35, and 45% decrease, respectively, in β-galactosidase activities when compared to the WT LdtR. These results are in agreement with the reduced DNA binding ability of L61A and F64A mutants observed in EMSA.

![***In vivo* assessment of mutations in Benz1 on the modulation of gene expression by LdtR.** β-galactosidase activities (AU) were determined at mid-exponential phase in *Bacillus subtilis* cells grown in the absence (black bars) or presence (light gray bars) of 1 μM benzbromarone. The experiments were performed in triplicates and the statistical significance (*p* \< 0.05) of the β-galactosidase activities in the absence or presence of benzbromarone is depicted with an asterisk.](fmicb-06-01314-g005){#F5}

The modulatory effects of benzbromarone on the trans-criptional activity of LdtR or its mutant variants was then determined by measuring β-galactosidase activity. In *B. subtilis* strain BS6 containing the WT LdtR it was observed that the transcriptional activation of the reporter gene decreased as the concentration of benzbromarone increased in the media (Supplementary Figure S3). 1 μM benzbromarone reduced the β-galactosidase activity by 40%, while concentrations higher than 5 μM were found to be toxic to the cells (data not shown). Similar to the WT LdtR, a significant decrease (around 40%) in the β-galactosidase activity was observed in LdtR mutants Y81A and R37A in presence of 1 μM benzbromarone compared to the control conditions (*p* \< 0.05; **Figure [5](#F5){ref-type="fig"}**). The LdtR mutant N65A showed a non-statistically significant decrease of 12% in the β-galactosidase activity compared to the control cells grown in absence benzbromarone (*p* \< 0.05; **Figure [5](#F5){ref-type="fig"}**). In contrast, mutants T43A, L61A, and F64A, showed similar levels of β-galactosidase activity in presence or absence of benzbromarone (**Figure [5](#F5){ref-type="fig"}**). These results suggest that residues T43, L61, and F64 may mediate interactions of LdtR with benzbromarone *in vivo*.

Mutations in Benz1 Decreased the Osmotic Stress Tolerance in *S. meliloti*
--------------------------------------------------------------------------

As described earlier, the disruption of the *ldtR* homolog gene in *S. meliloti* (strain SMP2) resulted in decreased tolerance to osmotic stress. This phenotype could be rescued by the ectopic expression of WT LdtR (from *L. asiaticus*, strain SMP2B; [@B37]). To determine the effect of mutations in Benz1 on the tolerance to osmotic stress, we used strain SMP2 (*ldtR*~Smc~ mutant) as the recipient strain. The SMP2 strain was transformed with the empty pBBR1MCS-5 vector as a control (strain SMP2A), WT LdtR (strain SMP2B), or the Benz1 mutants T43A, L61A, or F64A (strains SMP4A, SMP4B, or SMP4C, respectively; **Table [1](#T1){ref-type="table"}**). The tolerance to osmotic stress was assessed by determining the growth rate constant (*k*) and the mean generation time (*g*). To this end, each *S. meliloti* strain was grown in liquid cultures with increasing concentrations of sodium chloride, in presence or absence of 25 μM benzbromarone (**Table [4](#T4){ref-type="table"}**).

###### 

Mutations in LdtR Benz1 pocket reduce osmotic stress tolerance in *S. meliloti*.

  *S. meliloti* strain   Relevant genotype                     Growth rate constant, *k* (generations/h)^1^   Mean generation time (h)^2^   Growth rate constant, *k* (generations/h)   Mean generation time (h)
  ---------------------- ------------------------------------- ---------------------------------------------- ----------------------------- ------------------------------------------- --------------------------
                                                               **No benzbromarone**                           **25 μM benzbromarone**                                                   
  SMP5                   1021-pBBR1MCS-5                       0.061 ± 0.003                                  16.4                          0.044 ± 0.003                               22.7
  SMP2A                  Δ*ldtR*~SMc~-pBBR1MCS-5               0.043 ± 0.003                                  23.3                          0.042 ± 0.002                               23.8
  SMP2B                  Δ*ldtR*~SMc~-pBBR1MCS-5::LdtR         0.056 ± 0.004                                  17.9                          0.045 ± 0.002                               22.2
  SMP4A                  Δ*ldtR*~SMc~-pBBR1MCS-5::LdtR(T43A)   0.057 ± 0.002                                  17.5                          0.056 ± 0.004                               17.9
  SMP4B                  Δ*ldtR*~SMc~-pBBR1MCS-5::LdtR(L61A)   0.057 ± 0.003                                  17.5                          0.056 ± 0.005                               17.9
  SMP4C                  Δ*ldtR*~SMc~-pBBR1MCS-5::LdtR(F64A)   0.059 ± 0.002                                  16.9                          0.058 ± 0.003                               17.2

1

Growth rate constant (
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) was calculated from the plot of log

2

OD600 versus time.
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The mean generation time was calculated as 1/

k
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When grown in presence of 50 mM NaCl, the *S. meliloti* WT strain harboring an empty pBBR1MCS-5 plasmid (SMP5) had a duplication time of 16.4 h while in the *ldtR*~Smc~ mutant SMP2A, the duplication time increased by 42% (23.3 h). In contrast, the strain SMP2B (containing the WT LdtR from *L. asiaticus*) showed a 9% increase (17.9 h) in the duplication time when compared to the WT strain (**Table [4](#T4){ref-type="table"}**). These results confirmed that LdtR from *L. asiaticus* is able to complement the activity of its homolog in *S. meliloti.* Similarly, strains SMP4A, SMP4B, or SMP4C, complemented with Benz1 mutants, showed a similar effect to the WT LdtR (strain SMP2B) in the duplication time (17.5, 17.5, and 16.9 h, respectively, **Table [4](#T4){ref-type="table"}**).

The effect of benzbromarone was determined in each *S. meliloti* strain grown in the presence of 50 mM NaCl (**Table [4](#T4){ref-type="table"}**). For strain SMP2A, the absence or presence of benzbromarone did not affect the generation time (23.3 and 23.8 h, respectively). However, the addition of benzbromarone caused strains SMP5 and SMP2B to increase the duplication time by 39 and 25%. Interestingly, in strains SMP4A, SMP4B, or SMP4C, no statistical differences in the duplication time were observed. These results indicate that binding of benzbromarone to WT LdtR may competitively inhibit the binding of an unknown native ligand, decreasing the binding affinity of LdtR to DNA. Consequently, a reduced osmotic stress tolerance is observed. The addition of benzbromarone to mutants in Benz1 (strains SMP4A, SMP4B, or SMP4C) had no effect on tolerance to osmotic stress. Taken together, these results confirmed the role of residues T43, L61, and F64 in mediating interactions with benzbromarone.

Discussion
==========

Benzbromarone was previously identified as an effector molecule of LdtR activity *in vivo* and *in vitro* ([@B37]). Although benzbromarone might not be a native ligand for LdtR, previous results indicated that it competes with a yet unknown native ligand to decrease binding of LdtR to its cognate binding site, thus inhibiting transcriptional activation ([@B37]). In this report, using structural modeling we proposed Benz1 as the benzbromarone binding pocket in LdtR. The role of the residues T43, L61, and F64 in the modulation of transcriptional activity by benzbromarone was evaluated *in vitro*, through EMSA and ITC titrations, and *in vivo* using reporter assays and genetic complementation in model microorganisms.

Despite the large number of MarR homologs described in diverse microbial genomes, the affinities and stoichiometry of effector molecules has only been characterized in a few members. We determined that benzbromarone binds LdtR with an affinity within the low micromolar range (*K~D~* = 4.0 ± 1.6 μM) and a stoichiometry close to 0.5:1. Although the initial docking prediction suggested the presence of two ligand pockets in the LdtR dimer, the ITC data confirmed that only one site in the dimeric LdtR is occupied by benzbromarone. The stoichiometry of the reaction between benzbromarone and LdtR follow the half-of-the-sites reactivity phenomena ([@B30]; [@B2]), where the binding of the first molecule of benzbromarone may induced a conformational change in LdtR that precludes the binding of the second molecule in the opposite ligand binding pocket. These results may explain, at the biochemical level, the large structural movement observed in the MTH313 DNA binding lobes upon binding of salicylate in the SAL1 pocket. In absence of salicylate, the DNA binding domains of MTH313 are separated by 14 Å while in presence of salicylate, the DNA binding lobes are separated by 21 Å ([@B45]). This movement would allow the binding or release of the protein from the cognate promoter. Furthermore, the affinity value between benzbromarone and LdtR is similar to those reported for other MarR homologs, including EmrR binding to CCCP (between 2 and 25 μM; [@B6]; [@B53]), and ST1710 binding to ethidium (13.7 μM; [@B54]). For non-cooperative binders, the reported stoichiometry fall within a narrow range from 2:1 for novobiocin: LVIS553 ([@B39]) to 1:1 for ethidium: ST1710 or CCCP: ST1710 ([@B54]).

The availability of crystal structures for several members of the MarR family have provided insights into the binding sites of several molecules; however, the functional relevance of these sites has only been addressed in a few cases. In *E. coli*, the structure of MarR showed salicylate bound to sites A and B, both located in the DNA binding domain ([@B1]). In contrast, in MTH313 salicylate was located in the dimer interface in two asymmetric pockets, SAL1 and SAL2 ([@B45]). A recent report showed that mutagenesis of the residues in the SAL-A and SAL-B pockets in *E. coli* did not affect the interactions with salicylate ([@B12]). However, mutations in residues located in the SAL1 pocket (corresponding to those in MTH313) showed decreased binding to salicylate. Here, we performed a detailed structure based site-directed mutagenesis in LdtR to show that benzbromarone may bind to residues T43, L61, F64 in Benz1 (equivalent to SAL1 pocket), while residues in the predicted SAL2 pocket were not involved in ligand binding. These results are in agreement with our previous findings in *Lactobacillus brevis*, where mutations in the LVIS553 predicted SAL1 pocket impaired binding to its native ligand novobiocin, and mutations in the TstR SAL1 equivalent pocket impaired binding to sulfite ([@B39], [@B38]). Although the decreased interaction between the ligand and the mutants T43A, L61A, and F64A may suggest that these residues are involved in the interaction with benzbromarone, the possibility that the decreased interaction is due to changes in the overall structure of the dimer cannot be ruled out. Altogether, these data indicate that small molecules binding in the SAL1 pocket might be a common regulatory mechanism in the MarR family of regulators.

A structural alignment of LdtR homologs showed that all residues in the Benz1 pocket, with the exception of T43 (often replaced by isoleucine), are conserved in other rhizobiales (Supplementary Figure S4). These observations suggest that residues in Benz1 may also be involved in sensing the natural ligand of LdtR, which acts as an inducer of DNA binding. The conservation of key amino acids in the ligand binding pocket in other causative agents of HLB, such as *L. americanus* and *L. africanus*, provides the foundation for the use of Benz1 as an attractive target for the design of novel and environmentally safer therapeutic agents to treat HLB.

In summary, the identification of the precise location of the ligand pocket aids in the understanding of the mechanism of signal transduction for the MarR family, while the definition of key chemical moieties in the ligand binding pocket will: (i) provide clues into the ligands that are specifically sensed by transcription factors, improving their functional classification; and (ii) aid in the design of new and safer synthetic molecules that specifically target transcription factors, for use as new therapeutics against microorganisms involved in pathogenesis.
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